MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Ovarian cancer diagnosis and treatment
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,301 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,301 works in the cohort · of 4,299,418page 19 of 47

Labels cover 7 of 2,301 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,301 of 2,301 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Intratesticular borderline serous tumor
Layla Abdullah, RICHTA GUPTA, A ARNST
2006· article· en· International Journal of Urology· Medicine
machine prediction:candidate · noneconsensus · none
15
citations
affunlabeled
OV21/PETROC: A randomized Gynecologic Cancer Intergroup (GCIG) phase II study of intraperitoneal (IP) versus intravenous (IV) chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer (EOC).
Helen Mackay, Christopher Gallagher, Wendy R. Parulekar, Jonathan A. Ledermann, Deborah K. Armstrong, Charlie Gourley +13 more
2016· article· en· Journal of Clinical Oncology· Medicine
machine prediction:candidate · noneconsensus · none
15
citations
affunlabeled
Safety findings from FORWARD II: A Phase 1b study evaluating the folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC) mirvetuximab soravtansine (IMGN853) in combination with bevacizumab, carboplatin, pegylated liposomal doxorubicin (PLD), or pembrolizumab in patients (pts) with ovarian cancer.
David M. O’Malley, Kathleen N. Moore, Ignace Vergote, Lainie P. Martin, Lucy Gilbert, Antonio González-Martı́n +4 more
2017· article· en· Journal of Clinical Oncology· Medicine
machine prediction:candidate · noneconsensus · none
14
citations
affunlabeled
Squamous Lesions of the Ovary
Etienne Mahé, Monalisa Sur
2011· review· en· Archives of Pathology & Laboratory Medicine· Medicine
machine prediction:candidate · noneconsensus · none
14
citations
affno abstractunlabeled
Ovarian torsion in a 20-year-old patient
Chris Martin, Kirk Magee
2006· article· en· Canadian Journal of Emergency Medicine· Medicine
machine prediction:candidate · noneconsensus · none
14
citations
affno abstractunlabeled
Immunohistochemical and selected genetic reflex testing of all uterine leiomyosarcomas and STUMPs for ALK gene rearrangement may provide an effective screening tool in identifying uterine ALK-rearranged mesenchymal tumors
Nikola Ptáková, Markéta Miesbauerová, Ján Kosťun, Petr Grossmann, Henrieta Šidlová, Jaroslav Pavelka +4 more
2018· article· en· Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin· Medicine
machine prediction:candidate · noneconsensus · none
14
citations
affunlabeled
Socioeconomic Burden of Ovarian Cancer in 11 Countries
Brian Hutchinson, Mikis Euripides, Frances Reid, Gavin Allman, Lillian C Morrell, Garrison Spencer +4 more
2025· article· en· JCO Global Oncology· Medicine
machine prediction:candidate · noneconsensus · none
14
citations
affunlabeled
Markers of Oxidative Stress and Inflammation in Ascites and Plasma in Patients with Platinum‐Sensitive, Platinum‐Resistant, and Platinum‐Refractory Epithelial Ovarian Cancer
Rafael Cantón, Alejandra Guillermina Miranda‐Díaz, Jose Luis Bañuelos-Ramírez, Sandra Carrillo-Ibarra, Sonia Sifuentes-Franco, José Alberto Castellanos‐González +1 more
2017· article· en· Oxidative Medicine and Cellular Longevity· Medicine
machine prediction:candidate · noneconsensus · none
14
citations

How this was built: Screen · Findings · About